Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept. (2010). Farmeconomia. Health Economics and Therapeutic Pathways, 11(2), 63-76. https://doi.org/10.7175/fe.v11i2.184